3136 results for «3096»

Filter By

3136 results

Rapid-fire abstracts: Session 8

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...

Rapid-fire abstracts: Session 8

Mitral valve-in-valve interventions

Discover various compelling mitral valve-in-valve interventions in this session: bioprosthetic valve dislodgment during transapical valve-in-valve-TMVR, surgical bioprosthetic valve fracture for optimising haemodynamics of mitral valve-in-valve procedure, valve-in-valve TMVR in rheumatic mitral stenosis, and more!

Mitral valve-in-valve interventions

TAVI in TAVI

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of challenging cases in this session: valve-in-valve in a previous TAVR with healed endocarditis and aortic pseudoaneurysm closure, one-year SAPIEN 3 ultra failure treated with TAV-in-TAV with an Evolut Pro+ system, transcatheter valve implantation and coronary protection in a patient with prior valve-in-valve, and...

TAVI in TAVI

Rapid-fire clinical cases: Session 7

29 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: simultaneous transcatheter edge-to-edge repair of mitral and tricuspid valve, transcatheter valve implantation in mitral and tricuspid valve position, TEER failure in mitral and tricuspid position: troubleshooting approach for a rare but still eventful case,...

Rapid-fire clinical cases: Session 7

Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different needs of mitral and tricuspid patients, to appreciate what optimal medical therapy really means and to improve your knowledge of the anticoagulant requirements for different patient populations.

Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care

TAVI: new devices and procedural refinements

27 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to TAVI new devices and procedural refinements to learn more about Meril's Myval transcatheter heart valve, the newest EVOLUT-FX self-expanding supra-annular valve, the OctaAlign technique with the novel Myval octacor transcatheter heart valve, and more!

TAVI: new devices and procedural refinements

TAVI innovations

27 Nov 2022 – From PCR London Valves 2022

Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!

TAVI innovations

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Top Late-Breaking Trials

TMVR challenges

27 Nov 2022 – From PCR London Valves 2022

Challenges in this session of PCR LV 2022 include hybrid valve implantation for mitral annular calcification, transcatheter double-valve implantation complicated by mitral bioprosthesis migration, and transcatheter transseptal mitral valve implantation. Watch now to find out more!

TMVR challenges

Clinical outcomes after TAVI: Session 1

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about clinical outcomes after TAVI thanks to a selection of abstracts submitted during PCR LV 2022: definition of transcatheter heart valve orientation in bicuspid aortic valve with the DA VINCI study, TAVI with latest device iterations in patients with very...

Clinical outcomes after TAVI: Session 1

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn about the latest news in the field of mitral valve intervention and get insights into its current slow progress, which may be caused by clinical, anatomical or technological factors.

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

TAVI complications: Session 2

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover how to face various TAVI complications thanks to a selection of cases presented during PCR LV 2022: percutaneous management of annular rupture during TAVR, syncope after transaortic valve replacement, peri-TAVI papillary muscle rupture, and more!

TAVI complications: Session 2

Is frailty still relevant after 20 years of TAVI?

28 Nov 2022 – From PCR London Valves 2022

Consult this session to gain further knowledge of the frailty syndrome, to understand its relevance in today's patient population and to learn how to measure it using validated tools.

Is frailty still relevant after 20 years of TAVI?

Combined valve interventions

28 Nov 2022 – From PCR London Valves 2022

Among the very interesting cases presented in this PCR LV 2022 session, watch the 1st case of TMVR and TTVR in a patient with the use of dedicated investigational devices, simultaneous transcatheter mitral and tricuspid approach in a patient with dextrocardia, or simultaneous mitral valve-in-valve, tricuspid...

Combined valve interventions

Challenging scenarios: bicuspid aortic valves

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the variety of bicuspid aortic valve phenotypes and their impact on procedural outcomes, the pre-procedural planning and optimal procedural technique in this challenging patient cohort, as well as the key considerations for TAVI in younger patients with a bicuspid aortic valve.

Challenging scenarios: bicuspid aortic valves

How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair

28 Nov 2022 – From PCR London Valves 2022

Consul this session to learn more about the available treatment options after failed mitral surgical or transcatheter procedures, the factors that increase the likelihood of residual/recurrent mitral regurgitation, and more!

How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair

TAVI complications: Session 3

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover how to manage various TAVI complications: complex iliofemoral artery dissection following TAVI, ruptured TAVI balloon, displacement of the transcatheter aortic valve prosthesis, and much more!

TAVI complications: Session 3

Rapid-fire abstracts: Session 9

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of different aortic valve calcification pattern on the haemodynamic performance of self-expanding intra-annular transcatheter heart valve, device failure in bicuspid aortic stenosis following TAVR, the learning curve and clinical outcomes in...

Rapid-fire abstracts: Session 9

Transcatheter mitral valve interventions: clinical outcomes 1

28 Nov 2022 – From PCR London Valves 2022

Consult this session on transcatheter mitral valve interventions to discover a selection of abstracts submitted during PCR London Valves 2022: one-year outcomes for transcatheter mitral repair from the MiCLASP study, the Edwards PASCAL transcatheter mitral valve repair system study, one-year outcomes of Tendyne TMVR treating symptomatic MR,...

Transcatheter mitral valve interventions: clinical outcomes 1

Transcatheter tricuspid interventions: emerging evidence

29 Nov 2022 – From PCR London Valves 2022

Get insights into the latest studies regarding transcatheter tricuspid interventions with this selection of presentations on TriCLASP, bRIGHT, PASTE, EVALUATE, and more!

Transcatheter tricuspid interventions: emerging evidence
Didn’t find what you were looking for?